About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The search for quality and innovation has always been an inherent part of the activity of the Stroke Research Group and represents the common thread that leads us to excellence and continuous improvement.
In recent years, the Stroke Research Group has established itself as a leader in the management, recruitment and international coordination of multicenter clinical trials, as well as in the development of patents for new thrombectomy devices and the creation of new technological solutions and digital platforms to improve the diagnosis, treatment and follow-up of stroke patients. Robust strategic alliances have also been consolidated with public and private entities that ensure the viability and scalability of the research projects initiated in our group.
The Stroke Research Group is made up of a transversal and multidisciplinary team that shares a common idea: to contribute from its area of knowledge to the care and management of stroke through the effective transfer of knowledge and the complementarity of the processes of clinical research.
IP: Marc Ribó Jacobi Collaborators: Alvaro Garcia Tornel Garcia Camba, Judit Álvarez González Funding agency: Instituto de Salud Carlos III Funding: 180000 Reference: JR22/00046 Duration: 01/01/2023 - 31/12/2026
IP: Carlos Molina Cateriano Collaborators: Maria Baladas Orti, Ester Sanchez Gavilan, Cristina Guirao Martinez, Estefania Montiel, Marina Jimenez Iglesias, Lidia Garcia Guillamón, Federica Rizzo, Marta Aurora Rubiera Del Fueyo, David Rodriguez Luna, Manuel Requena Ruiz, Marta Olive Gadea, Alvaro Garcia Tornel Garcia Camba, Marc Rodrigo Gisbert Funding agency: EUROPEAN COMMISSION Funding: 468090 Reference: HARMONICS_EIT-HEALTH-BP2022 Duration: 01/01/2022 - 31/12/2024
IP: Marc Ribó Jacobi Collaborators: Marta Aurora Rubiera Del Fueyo, Carlos Molina Cateriano, Federica Rizzo Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 437334 Reference: CPP2021-008378 Duration: 01/03/2022 - 28/02/2025
IP: Deborah Pareto Onghena Collaborators: Ingrid Galán Cartaña, Herena Eixarch Ahufinger, M Jesus Arevalo Navines, Andrea De Barros Figueredo, Neus Mongay Ochoa, Giorgio Colangelo Funding agency: Instituto de Salud Carlos III Funding: 87120 Reference: PI22/01709 Duration: 01/01/2023 - 31/12/2025
PMID: 37693757 Journal: Frontiers in Neurology Year: 2023 Reference: Front Neurol. 2023 Aug 24;14:1274123. doi: 10.3389/fneur.2023.1274123. eCollection 2023. Impact factor: Publication type: Editorail in international publication Authors: Karapanayiotides, Theodoros; Lioutas, Vasileios-Arsenios; Mitsias, Panayiotis; Montalescot, Gilles; Rubiera, Marta et al. DOI: 10.3389/fneur.2023.1274123
PMID: 37709355 Journal: AMERICAN JOURNAL OF NEURORADIOLOGY Year: 2023 Reference: AJNR Am J Neuroradiol. 2023 Sep 14. doi: 10.3174/ajnr.A7996. Impact factor: Publication type: Paper in international publication Authors: Canals, Pere; Jablonska, Magda; Li, Jiahui; Li, Jiahui; Ortega, Santiago; Ribo, Marc; Ribo, Marc; Tiberi, Riccardo; Tomasello, Alejandro; Tomasello, Alejandro et al. DOI: 10.3174/ajnr.A7996
PMID: 37782494 Journal: JAMA Neurology Year: 2023 Reference: JAMA Neurol. 2023 Oct 2. doi: 10.1001/jamaneurol.2023.3344. Impact factor: Publication type: Paper in international publication Authors: Abboud, Halim; Albers, Gregory W; Amarenco, Pierre; Amarenco, Pierre; Ameriso, Sebastian; Anticoli, Sabrina; Arauz, Antonio; Arenillas, J F; Audebert, Henrich; Awada, Adnan et al. DOI: 10.1001/jamaneurol.2023.3344
PMID: 37793795 Journal: Journal of NeuroInterventional Surgery Year: 2023 Reference: J Neurointerv Surg. 2023 Oct 4:jnis-2023-020161. doi: 10.1136/jnis-2023-020161. Impact factor: Publication type: Paper in international publication Authors: Blanc, Raphael; Cancelliere, Nicole M; Clarencon, Frederic; Costalat, Vincent; De Villiers, Laetitia; Galvan Fernandez, Jorge; Gascou, Gregory; Gralla, Jan; Hernandez, David; Hernandez, David et al. DOI: 10.1136/jnis-2023-020161
PMID: 35508380 Journal: Journal of NeuroInterventional Surgery Year: 2022 Reference: J Neurointerv Surg. 2022 May 4. pii: neurintsurg-2022-018840. doi: 10.1136/neurintsurg-2022-018840. Impact factor: 5.836 Publication type: Paper in international publication Authors: Cano, David, Montiel, Estefania, Baladas, Maria, Sanchez-Gavilan, Esther, Paredes, Carolina, Rubiera, Marta, Requena, Manuel, Muchada, Marian, Olive Gadea, Marta, Garcia-Tornel, Alvaro et al. DOI: 10.1136/neurintsurg-2022-018840
PMID: 35491662 Journal: INTERVENTIONAL NEURORADIOLOGY Year: 2022 Reference: Interv Neuroradiol. 2022 May 2:15910199221095798. doi: 10.1177/15910199221095798. Impact factor: 1.61 Publication type: Paper in international publication Authors: Requena, Manuel, Pinana, Carlos, Olive-Gadea, Marta, Hernandez, David, Boned, Sandra, De Dios, Marta, Rodrigo, Marc, Rivera, Eila, Muchada, Marian, Cuevas, Jose Luis et al. DOI: 10.1177/15910199221095798
PMID: 35450927 Journal: Journal of NeuroInterventional Surgery Year: 2022 Reference: J Neurointerv Surg. 2022 Apr 21. pii: neurintsurg-2022-018889. doi: 10.1136/neurintsurg-2022-018889. Impact factor: 5.836 Publication type: Paper in international publication Authors: Castano, Oscar, Ribo, Marc, Kallmes, David F, Engel, Elisabeth, Galve, Inaki, Tiberi, Riccardo, Li, Jiahui, Tomasello, Alejandro, Requena, Manuel, Canals, Pere et al. DOI: 10.1136/neurintsurg-2022-018889
PMID: 35360928 Journal: STROKE Year: 2022 Reference: Stroke. 2022 Jul;53(7):2211-2219. doi: 10.1161/STROKEAHA.121.037577. Epub 2022 Apr 1. Impact factor: 7.914 Publication type: Paper in international publication Authors: Requena, Manuel, Ribo, Marc, Zamarro, Joaquin, Vega, Pedro, Blasco, Jordi, Gonzalez, Eva Maria, Del Mar Freijo, Maria, Mendez Cendon, Jose Carlos, de Miquel, Maria Angeles, Hernandez, David et al. DOI: 10.1161/STROKEAHA.121.037577
PMID: 33801197 Journal: Journal of Clinical Medicine Year: 2021 Reference: J Clin Med. 2021 Mar 2;10(5). pii: jcm10050989. doi: 10.3390/jcm10050989. Impact factor: 4.242 Publication type: Paper in international publication Authors: Marazuela, Paula, Bonaterra-Pastra, Anna, Faura, Julia, Penalba, Anna, Pizarro, Jesus, Pancorbo, Olalla, Rodriguez-Luna, David, Vert, Carla, Rovira, Alex, Pujadas, Francesc et al. DOI: 10.3390/jcm10050989
PMID: 33682453 Journal: STROKE Year: 2021 Reference: Stroke. 2021 May;52(5):1751-1760. doi: 10.1161/STROKEAHA.120.031800. Epub 2021 Mar 8. Impact factor: 7.914 Publication type: Paper in international publication Authors: Garcia-Tornel, Alvaro, Campos, Daniel, Rubiera, Marta, Boned, Sandra, Olive-Gadea, Marta, Requena, Manuel, Ciolli, Ludovico, Muchada, Marian, Pagola, Jorge, Deck, Matias et al. DOI: 10.1161/STROKEAHA.120.031800
PMID: 33589352 Journal: ULTRASOUND IN MEDICINE AND BIOLOGY Year: 2021 Reference: Ultrasound Med Biol. 2021 May;47(5):1428. doi: 10.1016/j.ultrasmedbio.2021.01.021. Epub 2021 Feb 12. Impact factor: 2.998 Publication type: Letter or abstract Authors: Juega, Jesus, Pagola, Jorge, Gonzalez-Alujas, Teresa, Rodriguez-Luna, David, Rubiera, Marta, Rodriguez-Villatoro, Noelia, Garcia-Tornel, Alvaro, Requena, Manuel, Deck, Matias, Sero, Laia et al. DOI: 10.1016/j.ultrasmedbio.2021.01.021
PMID: 33445800 Journal: Biomedicines Year: 2021 Reference: Biomedicines. 2021 Jan 12;9(1). pii: biomedicines9010072. doi: 10.3390/biomedicines9010072. Impact factor: 6.081 Publication type: Paper in international publication Authors: Vera, Rocio, Lebrato-Hernandez, Lucia, Arenillas, Juan F, Perez-Sanchez, Soledad, Montaner, Joan, Sanchez-Quesada, Jose Luis, Hernandez-Guillamon, Mar, Cardona Portela, Pere, Martinez-Zabaleta, Maite, Tur, Silvia et al. DOI: 10.3390/biomedicines9010072
PMID: 31845752 Journal: REVISTA DE NEUROLOGIA Year: 2020 Reference: Rev Neurol. 2020 Jan 1;70(1):19-22. doi: 10.33588/rn.7001.2019376. Impact factor: 0.562 Publication type: Letter or abstract Authors: Rubiera, M, Vert, C, Muchada, M, Deck, M, Anguizola-Tamayo, D A, Ballve-Martin, A, Campos-Fernandez, D, Morais-Dias, M, Garcia-Tornel, A et al. DOI: 10.33588/rn.7001.2019376
PMID: 31672489 Journal: NEUROSCIENCE LETTERS Year: 2020 Reference: Neurosci Lett. 2020 Jan 1;714:134580. doi: 10.1016/j.neulet.2019.134580. Epub 2019 Oct 28. Impact factor: 2.274 Publication type: Paper in international publication Authors: Ramiro, Laura, Simats, Alba, Penalba, Anna, Garcia-Tornel, Alvaro, Rovira, Alex, Mancha, Fernando, Bustamante, Alejandro, Montaner, Joan et al. DOI: 10.1016/j.neulet.2019.134580
UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.
The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.
Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.
